# Cantor BioConnect, Inc. – FDA Inspection, Mar 24, 2026

Source: https://www.keypedia.com/records/fda_inspections/cantor-bioconnect-inc/606f4ba3-5651-413a-b5b8-df5cceefc700
Source feed: FDA_Inspections

> FDA inspection 1309164 of Cantor BioConnect, Inc., March 24, 2026. 2 citations under 21 CFR parts 600 and 606. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1309164
- Company Name: Cantor BioConnect, Inc.
- Inspection Date: 2026-03-24
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Los Angeles District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1200803 - 2023-03-22](https://www.keypedia.com/records/fda_inspections/cantor-bioconnect-inc/9de06b39-78c0-472c-a6ee-526e4a7e53f0)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/creighton-t-tuzon/be0d09c0-59f4-48c3-9e3d-a1ceb2587e3e)
- [Issuing Officer](https://www.keypedia.com/people/james-a-banks/6838e911-c630-4a7c-8198-f3936ef6c5f8)

Company: https://www.keypedia.com/companies/cantor-bioconnect-inc/981435e7-15fc-4730-bb5e-ceb13c11f367

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b
